These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 31581174)

  • 1. Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes.
    Park E; Rawson S; Li K; Kim BW; Ficarro SB; Pino GG; Sharif H; Marto JA; Jeon H; Eck MJ
    Nature; 2019 Nov; 575(7783):545-550. PubMed ID: 31581174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into the BRAF monomer-to-dimer transition mediated by RAS binding.
    Martinez Fiesco JA; Durrant DE; Morrison DK; Zhang P
    Nat Commun; 2022 Jan; 13(1):486. PubMed ID: 35078985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK.
    Brennan DF; Dar AC; Hertz NT; Chao WC; Burlingame AL; Shokat KM; Barford D
    Nature; 2011 Apr; 472(7343):366-9. PubMed ID: 21441910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryo-EM structure of a dimeric B-Raf:14-3-3 complex reveals asymmetry in the active sites of B-Raf kinases.
    Kondo Y; Ognjenović J; Banerjee S; Karandur D; Merk A; Kulhanek K; Wong K; Roose JP; Subramaniam S; Kuriyan J
    Science; 2019 Oct; 366(6461):109-115. PubMed ID: 31604311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-Raf autoinhibition in the presence and absence of 14-3-3.
    Zhang M; Jang H; Li Z; Sacks DB; Nussinov R
    Structure; 2021 Jul; 29(7):768-777.e2. PubMed ID: 33711246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the BRAF-MEK complex reveals a kinase activity independent role for BRAF in MAPK signaling.
    Haling JR; Sudhamsu J; Yen I; Sideris S; Sandoval W; Phung W; Bravo BJ; Giannetti AM; Peck A; Masselot A; Morales T; Smith D; Brandhuber BJ; Hymowitz SG; Malek S
    Cancer Cell; 2014 Sep; 26(3):402-413. PubMed ID: 25155755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryo-EM structure of a RAS/RAF recruitment complex.
    Park E; Rawson S; Schmoker A; Kim BW; Oh S; Song K; Jeon H; Eck MJ
    Nat Commun; 2023 Jul; 14(1):4580. PubMed ID: 37516774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEK drives BRAF activation through allosteric control of KSR proteins.
    Lavoie H; Sahmi M; Maisonneuve P; Marullo SA; Thevakumaran N; Jin T; Kurinov I; Sicheri F; Therrien M
    Nature; 2018 Feb; 554(7693):549-553. PubMed ID: 29433126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution and characterization of BRAF in complex with 14-3-3 and KRAS4B on nanodiscs.
    Liu NF; Enomoto M; Marshall CB; Ikura M
    Protein Sci; 2024 Jun; 33(6):e5016. PubMed ID: 38747381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimerization Induced by C-Terminal 14-3-3 Binding Is Sufficient for BRAF Kinase Activation.
    Liau NPD; Venkatanarayan A; Quinn JG; Phung W; Malek S; Hymowitz SG; Sudhamsu J
    Biochemistry; 2020 Oct; 59(41):3982-3992. PubMed ID: 32970425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of RAF family kinases: new insights from recent structural and biochemical studies.
    Spencer-Smith R; Morrison DK
    Biochem Soc Trans; 2024 Jun; 52(3):1061-1069. PubMed ID: 38695730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryo-EM Structures of CRAF
    Dedden D; Nitsche J; Schneider EV; Thomsen M; Schwarz D; Leuthner B; Grädler U
    J Mol Biol; 2024 Mar; 436(6):168483. PubMed ID: 38331211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.
    Poulikakos PI; Zhang C; Bollag G; Shokat KM; Rosen N
    Nature; 2010 Mar; 464(7287):427-30. PubMed ID: 20179705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural snapshots of RAF kinase interactions.
    Rezaei Adariani S; Buchholzer M; Akbarzadeh M; Nakhaei-Rad S; Dvorsky R; Ahmadian MR
    Biochem Soc Trans; 2018 Dec; 46(6):1393-1406. PubMed ID: 30381334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF-inhibitor Associated MEK Mutations Increase RAF-Dependent and -Independent Enzymatic Activity.
    Emery CM; Monaco KA; Wang P; Balak M; Freeman A; Meltzer J; Delach SM; Rakiec D; Ruddy DA; Korn JM; Haling J; Acker MG; Caponigro G
    Mol Cancer Res; 2017 Oct; 15(10):1431-1444. PubMed ID: 28655712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Inactive Conformation-Selective Kinase Inhibitors by Utilizing Cascade Assays.
    Wang W; Krosky D; Ahn K
    Biochemistry; 2017 Aug; 56(34):4449-4456. PubMed ID: 28574701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric Kinase Inhibitors Reshape MEK1 Kinase Activity Conformations in Cells and In Silico.
    Fleischmann J; Feichtner A; DeFalco L; Kugler V; Schwaighofer S; Huber RG; Stefan E
    Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33808483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dimerization-dependent mechanism drives RAF catalytic activation.
    Rajakulendran T; Sahmi M; Lefrançois M; Sicheri F; Therrien M
    Nature; 2009 Sep; 461(7263):542-5. PubMed ID: 19727074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of RAF kinase activity by ATP is overcome by 14-3-3-induced dimerization.
    Liau NPD; Wendorff TJ; Quinn JG; Steffek M; Phung W; Liu P; Tang J; Irudayanathan FJ; Izadi S; Shaw AS; Malek S; Hymowitz SG; Sudhamsu J
    Nat Struct Mol Biol; 2020 Feb; 27(2):134-141. PubMed ID: 31988522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).
    Poulikakos PI; Persaud Y; Janakiraman M; Kong X; Ng C; Moriceau G; Shi H; Atefi M; Titz B; Gabay MT; Salton M; Dahlman KB; Tadi M; Wargo JA; Flaherty KT; Kelley MC; Misteli T; Chapman PB; Sosman JA; Graeber TG; Ribas A; Lo RS; Rosen N; Solit DB
    Nature; 2011 Nov; 480(7377):387-90. PubMed ID: 22113612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.